English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine Healthcare & Pharm
Malaysian Genomics Reports RM28.36 Million Full-Year Revenue
Aug 30, 2022 14:00 HKT
Strengthen technological innovation, Basecare Medical Announces 2022 Interim Results
Aug 29, 2022 18:30 HKT
Avance Clinical Sponsors Biotech Company of the Year Awards at Informa Pharma Intelligence Awards 2022
Aug 29, 2022 18:00 HKT
Malaysian Genomics Signs MoU with Ajlan to explore distribution of biopharmaceutical and genetic screening services in MENA region
Aug 29, 2022 14:00 HKT
Sirnaomics Achieves 100% Complete Response in Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma
Aug 29, 2022 12:46 HKT
Sirnaomics Advances GalAhead(TM)-Based RNAi Therapeutics for Treatment of Complement-Related Diseases
Aug 26, 2022 20:15 HKT
Zhaoke Ophthalmology Announces 2022 Interim Results
Aug 24, 2022 20:37 HKT
Sinomab Announces IND Application of SN1011 for the Treatment of Neuromyelitis Optica Spectrum Disorder Approved by NMPA
Aug 24, 2022 08:05 HKT
Avantor and Avantor Foundation Make a Difference by Providing Critical Health Services for Vulnerable Communities in Singapore
Aug 24, 2022 07:55 HKT
Oculis announces publication of Phase 2 data showing topical eye drops anti-TNFa agent licaminlimab (OCS-02) relieves persistent ocular discomfort in severe dry eye disease
Aug 23, 2022 20:37 HKT
Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion
Aug 23, 2022 19:51 HKT
Sirnaomics Becoming A Constituent of Hang Seng Family of Indexes
Aug 22, 2022 09:47 HKT
Peijia Medical Announces 2022 Interim Results: TaurusOne(R) and TaurusElite(R) Repeatedly Sets New Monthly Highs in Implantation Volume
Aug 22, 2022 09:29 HKT
IVD Medical Announces 2022 Interim Results
Aug 22, 2022 07:30 HKT
New Horizon Health Announced 2022 Interim Report: Revenue Up 414% YoY, Gross Margin Climbs to 82%
Aug 19, 2022 19:51 HKT
Led by Legend Capital, Multi-omics-leading Enterprise APTBIO Closes Series B with Hundreds of Millions of CNY
Aug 19, 2022 17:55 HKT
Taiwan Excellence Pavilion to showcase 10 leading medical tech innovators at Medical Fair Asia 2022
Aug 19, 2022 14:00 HKT
Taiwan Excellence Pavilion to showcase 10 leading medical tech innovators at Medical Fair Asia 2022
Aug 19, 2022 14:00 HKT
Sirnaomics Doses the First Patient in Phase I/II Clinical Study of RNAi Therapeutic STP705 for Treatment of Facial Squamous Cell Skin Cancer In Situ
Aug 19, 2022 11:30 HKT
Malaysian Genomics Explores Strategic Partnership with MAHSA Health through MoU
Aug 18, 2022 18:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: